A few weeks ago we released '50 Nordic life science startups to look out for in 2019'. The Nordic region has long produced world-leading science and innovation. Despite this, growth and venture funding is lacking compared with other hubs and Nordic companies face a number of specific challenges in their ongoing funding, growth, development and internationalisation.
As a taster of what's in the eBook, take a look below at 5 of our featured Norwegian companies that should be on your radar in 2019
Age Labs is a molecular diagnostics company focused on reducing the cost of developing drugs by accurately measuring your biological age. Age Labs is a privately held company that and is a biomarker for aging which is accurate, affordable and quick.
Hy5Pro AS is a Norwegian Medtech company that develops cost effective hydraulic hand prosthetics. The company believes that all people, across all geographic, demographic and socioeconomic areas should have the right to the highest possible quality of life, including full mobility. Through the years, the company has driven innovation and invested in creating a hand prosthetic with optimal functionality – at a reasonable price
Mode Sensors AS (Mode) is a digital healthcare company redefining the way hydration is clinically diagnosed by combining our wearable sensor technology with cloudbased data analytics and machine-learning. We are building technology enabling the next generation of healthcare services.
Pharmasum Therapeutics AS is a private Norwegian specialty pharmaceutical company focused on the discovery and development of differentiated drugs for the treatment of autoimmune / metabolic and neurological diseases.Founded in 2014 on the spin-out of industrial research on protein kinases, Pharmasum has offices in Tromsø and Oslo in Norway, and representation in the UK and USA.
RESPINOR is developing a novel, non-invasive, ultrasoundbased medical device for continuous diaphragm monitoring, the main breathing muscle. RESPINOR’s technology is the winner of Horizon 2020 funding both in phase I and II. Our technology has a broad range of potential benefits and represents a technology platform for applications in critical care and in respiratory medicine
We're excited to be welcoming many of these companies to our 2nd LSX Nordic Congress, Stockholm, 28-29 August.
There's also an exclusive offer for our LSX Nordic Congress for all readers!